Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9957526 Delivery methods and compositions for nuclease-mediated genome engineering

Patent 9957526 was granted and assigned to Sangamo Therapeutics on May, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Currently, there are no issues on this topic.

Find more entities like US Patent 9957526 Delivery methods and compositions for nuclease-mediated genome engineering

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo